8 results
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Organizing Pneumonia - Clinical ... pattern, irregular lines ... Organizing Pneumonia Treatment ... #BOOP #pulmonary ... ILD #diagnosis #management
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... US and updated treatment ... : SARS-CoV-2, 2019 ... unilateral* • POCUS ... Cheatsheet #Diagnosis #Management
COVID-19 - Subpleural Consolidations on Lung POCUS

Doing daily POCUS LUS for ICU COVID-19 patients in Singapore
and density of B lines ... are co-relate with ... Helps with management ... #clinical #lung ... #ultrasound #pulmonary
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
Illness Script PATHOPHYSIOLOGY ... DIAGNOSTICS: Clinical ... , neoplastic) TREATMENT ... Pneumonia #diagnosis #management ... #pulmonary
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... characteristic features Clinical ... cough Pleuritic CP ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Acromegaly - Diagnosis and Management Summary - GrepMed Handbook 

Clinical Presentation: 
 • Classic Acromegaly: frontal
GrepMed Handbook Clinical ... malignancy Pathophysiology ... : • 1st line - ... Endocrinology #Treatment ... #Pathophysiology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... characteristic features Clinical ... cough Pleuritic CP ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... , INC risk PE, Pulmonary ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... Rheumatology #Diagnosis #Management